Nationwide Fund Advisors Regeneron Pharmaceuticals, Inc. Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$358.63 - $469.95 $26.9 Million - $35.2 Million	-74,885 Closed	0 $0
Q3 2017 Oct 23, 2017	SELL	$431.38 - $504.0 $1.27 Million - $1.48 Million	-2,944 Reduced 3.78%	74,885 $33.5 Million
Q2 2017 Aug 10, 2017	BUY	N/A	77,829	77,829 $38.2 Million

1,461

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $124B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.